Effects of physostigmine and human butyrylcholinesterase on acoustic startle reflex and prepulse inhibition in C57BL/6J mice

Pharmacology Biochemistry and Behavior

Volumn 81, Issue 3, 2005, Pages 497-505

  Clark, Matthew G ^a,b   Sun, Wei ^a   Myers, Todd M ^a   Bansal, Reeta ^a   Doctor, Bhupendra P ^a   Saxena, Ashima ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b APG   (United States)

Author keywords

Acoustic startle reflex; Butyrylcholinesterase; Chemical warfare nerve agents; Cholinesterase; Physostigmine; Prepulse inhibition; Prophylaxis

Indexed keywords

CARBAMIC ACID DERIVATIVE; CHOLINESTERASE; PHYSOSTIGMINE; SODIUM CHLORIDE;

ACOUSTIC REFLEX; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CIRCULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; DRUG SAFETY; MALE; MOUSE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; STARTLE REFLEX; TIME;

ACOUSTIC STIMULATION; ANIMALS; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; HUMANS; INHIBITION (PSYCHOLOGY); MALE; MICE; MICE, INBRED C57BL; PHYSOSTIGMINE; REFLEX, ACOUSTIC; STARTLE REACTION; TIME FACTORS;

ANIMALIA;

EID: 22044452400     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.04.006     Document Type: Article

References (53)

1. N. Allon, L. Raveh, E. Gilat, E. Cohen, J. Grunwald, and Y. Ashani Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase Toxicol Sci 43 1998 121 128
2. Y. Ashani Prospective of human butyrylcholinesterase as a detoxifying antidote and potential regulator of controlled-release drugs Drug Dev Res 50 2000 298 308
3. Y. Ashani, S. Shapira, D. Levy, A.D. Wolfe, B.P. Doctor, and L. Raveh Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice Biochem Pharmacol 41 1991 37 41
4. E. Bodur, A.N. Cokugras, and E.F. Tezcan Inhibition effects of benactyzine and drofenine on human serum butyrylcholinesterase Arch Biochem Biophys 386 2001 25 29
5. R. Brandeis, L. Raveh, J. Grunwald, E. Cohen, and Y. Ashani Prevention of soman-induced cognitive deficits by pretreatment with human butyrylcholinesterase in rats Pharmacol Biochem Behav 46 1993 889 896
6. C.A. Broomfield, D.M. Maxwell, R.P. Solana, C.A. Castro, A.V. Finger, and D.E. Lenz Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates J Pharmacol Exp Ther 259 1991 633 638
7. C.A. Castro, T. Larsen, A.V. Finger, R.P. Solana, and S.B. McMaster Behavioral efficacy of diazepam against nerve agent exposure in rhesus monkeys Pharmacol Biochem Behav 41 1992 159 164
8. M. Davis Neurochemical modulation of sensory-motor reactivity: acoustic and tactile startle reflexes Neurosci Biobehav Rev 4 1980 241 263
9. B.P. Doctor, L. Raveh, A.D. Wolfe, D.M. Maxwell, and Y. Ashani Enzymes as pretreatment drugs for organophosphate toxicity Neurosci Biobehav Rev 15 1991 123 128
10. B.P. Doctor, D.M. Maxwell, Y. Ashani, A. Saxena, and R.K. Gordon New approaches to medical protection against chemical warfare nerve agents S.M. Somani J.A. Romano Jr. Chemical warfare nerve agents: toxicity at low levels 2001 CRC Press Washington, D.C. 191 214
11. M.A. Dunn, and F.R. Sidell Progress in medical defense against nerve agents Jama 262 1989 649 652
12. G.L. Ellman, K.D. Courtney, V. Andres Jr., and R.M. Feather-Stone A new and rapid colorimetric determination of acetylcholinesterase activity Biochem Pharmacol 7 1961 88 95
13. F. Fonnum, and D.M. Guttormsen Changes in acetylcholine content of rat brain by toxic doses of di-isopropyl phosphofluoridate Experientia 25 1969 505 506
14. P.J. Garry, L.C. Prince, and R.E. Notari Half-life of human serum cholinesterase following blood transfusion Res Commun Chem Pathol Pharmacol 8 1974 371 380
15. R.F. Genovese, and B.P. Doctor Behavioral and pharmacological assessment of butyrylcholinesterase in rats Pharmacol Biochem Behav 51 1995 647 654
16. M.A. Geyer, K. Krebs-Thomson, D.L. Braff, and N.R. Swerdlow Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review Psychopharmacology 156 2001 117 154
17. Guide for the Care and Use of Laboratory Animals Institute of Laboratory Animal Resources Commission on Life Sciences, National Research Council 1996 National Academy Press Washington, D.C.
18. G.C. Haggerty, P.J. Kurtz, and R.D. Armstrong Duration and intensity of behavioral change after sublethal exposure to soman in rats Neurobehav Toxicol Teratol 8 1986 695 702
19. T. Jenkins, D. Balinsky, and D.W. Patient Cholinesterase in plasma: first reported absence in the Bantu; half-life determination Science 156 1967 1748 1750
20. C.K. Jones, and H.E. Shannon Effects of scopolamine in comparison with apomorphine and phencyclidine on prepulse inhibition in rats Eur J Pharmacol 391 2000 105 112
21. C.K. Jones, and H.E. Shannon Muscarinic cholinergic modulation of prepulse inhibition of the acoustic startle reflex J Pharmacol Exp Ther 294 2000 1017 1023
22. L. Leadbeater, R.H. Inns, and J.M. Rylands Treatment of poisoning by soman Fundam Appl Toxicol 5 1985 S225 S231
23. D.E. Lenz, C.A. Broomfield, D.M. Maxwell, and D.M. Cerasoli Nerve agent bioscavengers: protection against high- and low-dose organophosphorus exposure S.M. Somani J.A. Romano Jr. Chemical warfare agents: toxicity as low levels 2001 CRC Press Washington, D.C. 215 243
24. S.M. Matzke, J.L. Oubre, G.R. Caranto, M.K. Gentry, and G. Galbicka Behavioral and immunological effects of exogenous butyrylcholinesterase in rhesus monkeys Pharmacol Biochem Behav 62 1999 523 530
25. D.M. Maxwell The specificity of carboxylesterase protection against the toxicity of organophosphorus compounds Toxicol Appl Pharmacol 114 1992 306 312
26. D.M. Maxwell, C.A. Castro, D.M. De La Hoz, M.K. Gentry, M.B. Gold, and R.P. Solana Protection of rhesus monkeys against soman and prevention of performance decrement by pretreatment with acetylcholinesterase Toxicol Appl Pharmacol 115 1992 44 49
27. J.H. McDonough Performance impacts of nerve agents and their phamacological countermeasures Mil Psychol 14 2002 93 119
28. J.H. McDonough Jr., and T.M. Shih Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology Neurosci Biobehav Rev 21 1997 559 579
29. J.H. McDonough Jr., N.K. Jaax, R.A. Crowley, M.Z. Mays, and H.E. Modrow Atropine and/or diazepam therapy protects against soman-induced neural and cardiac pathology Fundam Appl Toxicol 13 1989 256 276
30. D. Ostergaard, J. Viby-Mogensen, H.K. Hanel, and L.T. Skovgaard Half-life of plasma cholinesterase Acta Anaesthesiol Scand 32 1988 266 269
31. I.H. Philippens, O.L. Wolthuis, R.W. Busker, J.P. Langenberg, and B.P. Melchers Side effects of physostigmine as a pretreatment in guinea pigs Pharmacol Biochem Behav 55 1996 99 105
32. I.H. Philippens, B. Olivier, and B.P. Melchers Effects of physostigmine on the startle in guinea pigs: two mechanisms involved Pharmacol Biochem Behav 58 1997 909 913
33. L. Raveh, Y. Ashani, D. Levy, D. De La Hoz, A.D. Wolfe, and B.P. Doctor Acetylcholinesterase prophylaxis against organophosphate poisoning. Quantitative correlation between protection and blood-enzyme level in mice Biochem Pharmacol 38 1989 529 534
34. L. Raveh, J. Grunwald, D. Marcus, Y. Papier, E. Cohen, and Y. Ashani Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. In vitro and in vivo quantitative characterization Biochem Pharmacol 45 1993 2465 2474
35. L. Raveh, E. Grauer, J. Grunwald, E. Cohen, and Y. Ashani The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase Toxicol Appl Pharmacol 145 1997 43 53
36. Y. Rosenberg, C. Luo, Y. Ashani, B.P. Doctor, R. Fischer, and G. Wolfe Pharmacokinetics and immunologic consequences of exposing macaques to purified homologous butyrylcholinesterase Life Sci 72 2002 125 134
37. A. Saxena, L. Raveh, Y. Ashani, and B.P. Doctor Structure of glycan moieties responsible for the extended circulatory life time of fetal bovine serum acetylcholinesterase and equine serum butyrylcholinesterase Biochemistry 36 1997 7481 7489
38. F.T. Schuh Serum cholinesterase: effect on the action of suxamethonium following administration to a patient with cholinesterase deficiency Br J Anaesth 49 1977 269 272
39. O.U. Scremin, T.M. Shih, L. Huynh, M. Roch, R. Booth, and D.J. Jenden Delayed neurologic and behavioral effects of subtoxic doses of cholinesterase inhibitors J Pharmacol Exp Ther 304 2003 1111 1119
40. R.J. Servatius, J.E. Ottenweller, D. Beldowicz, W. Guo, G. Zhu, and B.H. Natelson Persistently exaggerated startle responses in rats treated with pyridostigmine bromide J Pharmacol Exp Ther 287 1998 1020 1028
41. R.J. Servatius, J.E. Ottenweller, W. Guo, D. Beldowicz, G. Zhu, and B.H. Natelson Effects of inescapable stress and treatment with pyridostigmine bromide on plasma butyrylcholinesterase and the acoustic startle response in rats Physiol Behav 69 2000 239 246
42. T.M. Shih Time course effects of soman on acetylcholine and choline levels in six discrete areas of the rat brain Psychopharmacology 78 1982 170 175
43. M.L. Sipos, V. Burchnell, and G. Galbicka Effects of selected anticholinergics on acoustic startle response in rats J Appl Toxicol 21 Suppl 1 2001 S95 S101
44. S.M. Somani, and S.N. Dube In vivo dose response relationship between physostigmine and cholinesterase activity in RBC and tissues of rats Life Sci 44 1989 1907 1915
45. J. Stovner, and K. Stadskleiv Suxamethonium apnoea terminated with commercial serum cholinesterase Acta Anaesthesiol Scand 20 1976 211 215
46. D.J. Triggle, Y.W. Kwon, P. Abraham, J.B. Pitner, S.W. Mascarella, and F.I. Carroll Synthesis, molecular modeling studies, and muscarinic receptor activity of azaprophen analogues J Med Chem 34 1991 3164 3171
47. D.J. Triggle, J.M. Mitchell, and R. Filler The pharmacology of physostigmine CNS Drug Rev 4 1998 87 136
48. J.J. Waite, and L.J. Thal The behavioral effects of heptylphysostigmine on rats lesioned in the nucleus basalis Neurosci Res 21 1995 251 259
49. I.B. Wilson, and S. Ginsburg A powerful reactivator of alkyl phosphate-inhibited acetylcholinesterase Biochim Biophys Acta 18 1955 168
50. A.D. Wolfe, R.S. Rush, B.P. Doctor, I. Koplovitz, and D. Jones Acetylcholinesterase prophylaxis against organophosphate toxicity Fundam Appl Toxicol 9 1987 266 270
51. A.D. Wolfe, D.W. Blick, M.R. Murphy, S.A. Miller, M.K. Gentry, and S.L. Hartgraves Use of cholinesterases as pretreatment drugs for the protection of rhesus monkeys against soman toxicity Toxicol Appl Pharmacol 117 1992 189 193
52. O.L. Wolthuis, I.H. Philippens, and R.A. Vanwersch Side effects of therapeutic drugs against organophosphate poisoning Neurotoxicol Teratol 11 1989 221 225
53. M.F. Wu, D.J. Jenden, M.D. Fairchild, and J.M. Siegel Cholinergic mechanisms in startle and prepulse inhibition: effects of the false cholinergic precursor N-aminodeanol Behav Neurosci 107 1993 306 316